Office of Research on Women’s Health (ORWH)
NIH’s ORWH Welcomes Four New Advisory Council Members
The Office of Research on Women’s Health (ORWH) at the National Institutes of Health (NIH) welcomes four new members to the Advisory Committee on Research on Women’s Health (ACRWH).
The ACRWH advises the ORWH director on NIH research activities on women’s health; reviews the women’s health research portfolio for NIH; surveys goals for scientific career development; and assists with ORWH’s role to ensure inclusion of women and minorities in NIH clinical research. ACRWH members are selected from among distinguished physicians, healthcare practitioners, scientists, and other health professionals who are not federal employees, and who have a clinical practice, research specialization, or professional expertise that includes a significant focus on research on women's health.
The new members each will serve four-year terms and join eight current ACRWH members. The new committee members are:
Angela Kashuba, B.Sc.PhM., Pharm.D, DAPCP, is an expert in clinical pharmacology and a professor of pharmacy and medicine at the University of North Carolina (UNC) at Chapel Hill. She is vice chair for research and graduate education within the Division of Pharmacotherapy and Experimental Therapeutics in the Eshelman School of Pharmacy. She also is director of the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core, and director of the pharmacology core for the UNC Delaney Care Collaboratory to Eradicate HIV Infection. Dr. Kashuba co-directs the T32-funded fellowship in clinical pharmacology, a joint program with UNC and Duke University. She is a founding member and co-chair for the annual International Workshop on HIV and Women and is a member of the organizing committee for the International Workshop on Clinical Pharmacology of HIV Therapy. She also is chair of the HIV Pharmacology Best Practices Working Group within the National Institute of Allergy and Infectious Diseases Division of AIDS, and is a member of the NIAID AIDS Discovery and Development of Therapeutics Study Section.
Valerie Montgomery Rice, M.D., is incoming president of Morehouse School of Medicine, effective July 2014, and currently serves as dean and executive vice president. She is the first African-American woman named to lead a freestanding medical school. Dr. Montgomery Rice also serves as professor, Department of Obstetrics and Gynecology, Morehouse School of Medicine, where she has served since 2011. She is a renowned infertility specialist and researcher with expertise in organizational management and public health policy. Her current includes a research partnership with the University of Zambia, which focuses on the development of a vaginal microbicide for the prevention of HIV. Dr. Montgomery Rice founded and is former director of the Center for Women's Health Research at Meharry Medical College, one of the nation's first research centers devoted to studying diseases that disproportionately impact women of color. She has held numerous senior leadership positions at some of the nation's most prestigious academic and health institutions, including administrative and faculty appointments at the University of Kansas School of Medicine prior to joining Meharry Medical College.
Judith Regensteiner, Ph.D., is director of the Center for Women’s Health Research and professor of Medicine in the Divisions of Internal Medicine and Cardiology at the University of Colorado Anschutz Medical Campus. Her research expertise is in the cardiovascular effects of diabetes with a specific focus on women with type 2 diabetes, since women appear to have more significant abnormalities than men with diabetes. She has been principal investigator or co-investigator of current and previous large grants in type 2 diabetes and peripheral arterial disease. As co-founder and director of the Center for Women’s Health Research at the University of Colorado Anschutz Medical Campus, Dr. Regensteiner leads an interdisciplinary team of researchers who focus on women’s health and sex difference research. The Center for Women’s Health Research seeks to accelerate improvements in women’s health by uncovering answers to medical questions related to cardiovascular disease and diabetes. Dr. Regensteiner is principal investigator and program director for the ORWH’s Building Interdisciplinary Research Careers in Women's Health program, a K-12 grant that funds early stage women’s health researchers, an American Diabetes Association grant, and is an investigator for the National Institutes of Health’s “Look Ahead” program.
Teresa K. Woodruff, Ph.D., is the Thomas J. Watkins Professor of Obstetrics & Gynecology, the vice chair of research (OB/GYN), the Chief of the Division of Reproductive Science in Medicine, Feinberg School of Medicine, and professor of Molecular Biosciences at the Weinberg College of Arts and Sciences at Northwestern University. She is an internationally recognized expert in ovarian biology and coined the term “oncofertility” to describe the merging of two fields: oncology and fertility. Dr. Woodruff was awarded a prestigious Roadmap Grant from the NIH (2007) for pioneering work accomplished in her lab. She now heads the Oncofertility Consortium , an interdisciplinary team of biomedical and social scientist experts from across the country. Dr. Woodruff has established a team of oncologists, fertility specialists, social scientists, educators and policy makers to translate her research to the clinical care of women who will lose their fertility due to cancer treatment. She has been an advocate for gender specificity in clinical trials in an effort to better understand the effects that technologies and procedures have on women and is the founding director of the Women’s Health Research Institute, which has as its mission ‘science to care’ and ensuring that sex and gender are part of the research mission. As an educator and mentor, she encourages young women to pursue careers in the sciences.